Jinyoung Lee

Jinyoung Lee

Auto-generated profile, based on publicly available information

Jinyoung Lee

Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
MBMinjung Bak
Minjung Bak
JLJinyoung Lee
Jinyoung Lee
MHMinseok Hong
Minseok Hong
DKDarae Kim
Darae Kim
JCJin-Oh Choi
Jin-Oh Choi
JYJeong Hoon Yang
Jeong Hoon Yang
Bak M, et al. J Korean Med Sci. 2025 Jul;40(29):e221. https://doi.org/10.3346/jkms.2025.40.e221

18 June 2026 in JACC: Case Reports
Verified
Journal Article
Open access
JLJinyoung Lee
Jinyoung Lee
DKDarae Kim
Darae Kim
DHDavid Hong
David Hong
JCJi Hyun Cha
Ji Hyun Cha
KNKang Noeul
Kang Noeul
JCJin-Oh Choi
Jin-Oh Choi
Eosinophilic myocarditis has heterogeneous presentations and may cause fulminant cardiogenic shock. A 35-year-old man with ulcerative colitis and eosinophilia developed cardiogenic shock after sequential biologic therapy (most recently vedolizumab) and corticosteroid withdrawal. He rapidly deteriorated with severe biventricular dysfunction (left ventricular ejection fraction 10%) and hypereosinophilia (eosinophil count 2,154/μL). Coronary angiography showed no obstructive disease, and cardiac magnetic resonance suggested diffuse myocardial involvement. Endomyocardial biopsy confirmed eosinophilic myocarditis. He required veno-arterial extracorporeal membrane oxygenation and high-dose intravenous methylprednisolone. Recurrent eosinophilia during tapering prompted use of mepolizumab, followed by recovery of left ventricular function. Biologic exposure with corticosteroid withdrawal was temporally associated with systemic eosinophilic activation, and histologic confirmation by biopsy enabled escalation to targeted therapy. In patients with inflammatory bowel disease receiving biologics, hypereosinophilia with acute heart failure should prompt evaluation for eosinophilic myocarditis. Early biopsy may enable timely escalation to targeted immunomodulatory therapy.

1 January 2026 in Journal of Korean Medical Science
Verified
Journal Article
Open access
HSHeayoung Shin
Heayoung Shin
SPSung-Ji Park
Sung-Ji Park
SOSoo-young Oh
Soo-young Oh
JSJihee Son
Jihee Son
JLJinyoung Lee
Jinyoung Lee
SPSeung Woo Park
Seung Woo Park
Shin H, et al. J Korean Med Sci. 2026 Jun;41:e145. https://doi.org/10.3346/jkms.2026.41.e145